• Proceedings of the KOR-BRONCHOESO Conference
• /
• 1983.05a
• /
• pp.10.1-10
• /
• 1983

We have analysed the 76 cases of the foreign bodies of our ENT department during the period from Jun. 1973 to Feb. 1983. The following results were obtained and were reported. 1) Distribution of these whole 105 cases, 68 cases (64.8 %) were lodged in esophagus, 13 cases (12.4 %) were in the nasal cavities, 9 cases (8.5 %) were in the oral cavity and throat, 8 cases (7.6 %) were in the air passages, and 7 cases (6.7 %) were in the external auditory canal. 2) The sorts of the esophageal foreign bodies, the coins were the most cases(53 cases - 77.9 %) and other sites were shown of variable kinds. 3) Age distribution of the esophageal foreign bodies were mostly in under 5 years of age (49 cases - 72 %) and in cases of the air passages, all the 8 cases were in under 10. 4) In the localities of the esophageal foreign bodies, first narrowing was the most frequent site (61 cases - 89.7 %), and of air passages, 6 cases were in the left main bronchus, more that of Rt. main bronchus. 5) During the lodgement of esophageal foreign bodies, 58 cases (85.3 %) were visited to our ENT department within 24 hours. In the cases of air passages, most were viaited in 3 to 7 days (6 cases -75 %).

• Korean Journal of Head & Neck Oncology
• /
• v.23 no.2
• /
• pp.153-156
• /
• 2007

Objectives : We study the feasibility and pharmacokinetics of cisplatin concurrent chemoradiation for advanced head and neck cancer patient undergoing hemodialysis. Materials and Methods : A 57-year old male with end stage renal disease developed stage III external auditory canal cancer. Complete resection surgery was done. Postoperative 6 months, local recurrence was occurred. Despite excision and adjuvant radiotherapy, local tumor was recurred. We decided to treat a cisplatin concurrent chemoradiotherapy. Cisplatin was administered at a dose of $20mg/m^2$ for 30 min. Hemodialysis was started 30 min after completion of the cisplatin infusion and performed for 4 hours. Hemodialysis was performed on day 3 and 5 of chemotherapy. Plasma samples were collected at specified times after administration of cisplatin. Result : At the end of the third cycle of cisplatin concurrent chemoradiotherapy, the tumor size was markedly decreased. The maximum plasma concentrations of plasma platinum and free platinum were 0.74 and $0.37{\mu}g/ml$ respectively. The area under the curve of plasma platinum and free platinum were 94.7 and $11.3{\mu}g{\cdot}h/ml$ respectively. Conclusion : We report a case of Cisplatin concurrent chemoradiation for hemodialysis patient with advanced head and neck cancer and suggest full dose cisplatin concurrent chemoradiotherpay is tolerable for these patients.